Form 4: Amgen EVP Jonathan P. Graham Reports Stock and Option Awards

Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., reports the acquisition of stock and option awards.

Summary

• On May 7, 2024, Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., reported transactions related to Amgen stock.
• Graham acquired 2,863 shares of common stock through Restricted Stock Units (RSUs) and 18,603 non-qualified stock options.
• The RSUs vest in three annual installments starting May 7, 2026, and the stock options are exercisable in three installments beginning the same date.
• Following these transactions, Graham beneficially owns 35,186 shares of Amgen common stock and 18,603 non-qualified stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices, aligning management interests with shareholders.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Future Outlook

The executive's holdings will increase as the RSUs vest and the stock options become exercisable, aligning their interests with the company's long-term performance.

Industry Context

Stock and option grants are a common practice in the pharmaceutical industry to incentivize executives and align their interests with shareholders.

Comparison to Industry Standards

• Amgen's equity compensation practices are generally in line with those of its peers in the biotechnology industry, such as Gilead Sciences, Biogen, and Regeneron Pharmaceuticals.
• These companies also utilize a mix of stock options and restricted stock units to incentivize their executives.
• The vesting schedules and exercise prices are typically structured to reward long-term value creation and align executive compensation with shareholder returns.

Stakeholder Impact

• The grant of equity to executives can positively impact shareholders by aligning management's interests with long-term value creation.
• Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Key Dates